Pranesh Kumar
Impact in
- Drug Discovery top 5%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 8
-
- Advanced Drug Delivery Systems 6
- Co-authors
- Sudipta Saha (32 shared papers)Ashok Kumar Singh (17 shared papers)Biswanath Maity (26 shared papers)Dinesh Kumar (16 shared papers)Amit K. Keshari (12 shared papers)Anand Prakash (7 shared papers)Vinit Raj (10 shared papers)Amit Rai (8 shared papers)
- Journals
- Redox Biology (3 papers)International Journal of Pharmaceutics (2 papers)International Immunopharmacology (2 papers)Mini-Reviews in Medicinal Chemistry (2 papers)Chemico-Biological Interactions (2 papers)
- Partner nations
- IndiaUnited StatesChina
In The Last Decade
Pranesh Kumar
56 papers receiving 849 citations
Peers
Comparison fields: 5 of 77
- Drug Discovery 10
- Biomaterials 162
- Pharmaceutical Science 61
- Pharmacology 81
- Endocrinology, Diabetes and Metabolism 78
Countries citing papers authored by Pranesh Kumar
This map shows the geographic impact of Pranesh Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pranesh Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pranesh Kumar more than expected).
Fields of papers citing papers by Pranesh Kumar
This network shows the impact of papers produced by Pranesh Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pranesh Kumar. The network helps show where Pranesh Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Pranesh Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 89 | |
| 2 | 2016 | 75 | |
| 3 | 2018 | 55 | |
| 4 | 2018 | 52 | |
| 5 | 2018 | 40 | |
| 6 | 2020 | 27 | |
| 7 | 2022 | 25 | |
| 8 | 2011 | 24 | |
| 9 | 2019 | 24 | |
| 10 | 2020 | 24 | |
| 11 | 2015 | 23 | |
| 12 | 2018 | 23 | |
| 13 | 2022 | 22 | |
| 14 | 2017 | 20 | |
| 15 | 2017 | 18 | |
| 16 | 2017 | 17 | |
| 17 | 2019 | 16 | |
| 18 | 2022 | 16 | |
| 19 | 2022 | 16 | |
| 20 | A double-blind trial of azathioprine in Crohn's disease. | 1971 | 15 |
About Pranesh Kumar
Pranesh Kumar is a scholar working on Biomaterials, Pharmaceutical Science, Pharmacology, Hepatology and Cardiology and Cardiovascular Medicine, having authored 58 papers that have together received 878 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Advanced Drug Delivery Systems (6 papers), Synthesis and biological activity (6 papers), Inflammatory mediators and NSAID effects (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer and biochemical research (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Drug Discovery (10 citations), Biomaterials (162 citations), Pharmaceutical Science (61 citations), Pharmacology (81 citations) and Endocrinology, Diabetes and Metabolism (78 citations). Pranesh Kumar has collaborated with scholars based in India, United States and China. Frequent co-authors include Sudipta Saha, Ashok Kumar Singh, Biswanath Maity, Dinesh Kumar, Amit K. Keshari, Anand Prakash, Vinit Raj, Amit Rai, Umesh Kumar and Atul Rawat. Their work appears in journals such as Redox Biology, International Journal of Pharmaceutics, International Immunopharmacology, Mini-Reviews in Medicinal Chemistry and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.